
1. Emerg Infect Dis. 2018 Jan;24(1):40-48. doi: 10.3201/eid2401.170864.

Drug-Resistant Polymorphisms and Copy Numbers in Plasmodium falciparum,
Mozambique, 2015.

Gupta H, Macete E, Bulo H, Salvador C, Warsame M, Carvalho E, MÃ©nard D, Ringwald 
P, Bassat Q, Enosse S, Mayor A.

One of the fundamental steps toward malaria control is the use of antimalarial
drugs. The success of antimalarial treatment can be affected by the presence of
drug-resistant populations of Plasmodium falciparum. To assess resistance, we
used molecular methods to examine 351 P. falciparum isolates collected from 4
sentinel sites in Mozambique for K13, pfmdr1, pfcrt, and pfdhps polymorphisms and
for plasmepsin2 (pfpm2) and pfmdr1 copy numbers. We found multiple copies of
pfpm2 in 1.1% of isolates. All isolates carried K13 wild-type alleles (3D7-like),
except 4 novel polymorphisms (Leu619Leu, Phe656Ile, Val666Val, Gly690Gly).
Prevalence of isolates with pfcrt mutant (K76T) allele was low (2.3%). Prevalence
of isolates with pfdhps mutant alleles (A437G and K540E) was >80%, indicating
persistence of sulfadoxine/pyrimethamine resistance; however, markers of
artemisinin were absent, and markers of piperaquine resistance were low.
Piperaquine resistance isolates may spread in Mozambique as
dihydroartemisinin/piperaquine drug pressure increases.

DOI: 10.3201/eid2401.170864 
PMCID: PMC5749434
PMID: 29260689  [Indexed for MEDLINE]

